Showing results (1541-1550 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|February 15, 2021
Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employersErin Lopata, Christopher Terrone, Ami Gopalan, et al.Journal of Managed Care & Specialty Pharmacy|February 24, 2021
Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patientsChad M Brummett, Jackie Evans-Shields, Christina England, et al.Journal of Managed Care & Specialty Pharmacy|August 28, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye diseaseDarrell E White, Laura H Hendrix, Lucille Sun, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims dataMeiqi He, Laura K Ferris, Nico Gabriel, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Trends in add-on medications following metformin monotherapy for type 2 diabetesElizabeth Cs Swart, Lynn M Neilson, Kiraat D Munshi, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Within-trial economic analysis of resource use from COMET-ICE: A phase 3 clinical trial evaluating sotrovimab for the treatment of patients with COVID-19 at high risk of progressionTasneem Lokhandwala, Mahip Acharya, Eileen Farrelly, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Is adding ribociclib to fulvestrant cost-effective in treating postmenopausal women with HR+/HER2- advanced or metastatic breast cancer? A US payer perspective cost utility analysisKevin Berrios, Alexandra Burum, Eunae Jeong, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysisCameron Karnick, Ashley Modany, Molly McGraw, et al.Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Health care resource utilization and costs among individuals with vs without Huntington disease in a US populationTu My To, Alex Exuzides, Ibrahim M Abbass, et al.Journal of Managed Care & Specialty Pharmacy|November 1, 2022
Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United StatesLia N Pizzicato, Aisha Vadhariya, Julie Birt, et al.Pageof 186